NCT00587470View on ClinicalTrials.gov

Angiotensin-II Blockade in Mitral Regurgitation

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions

Mitral Regurgitation

Interventions

DRUG

Candesartan

Maximum vasodilation.

DRUG

atacand

maximum vasodilation

DRUG

Placebo

Placebo

Trial Locations (1)

55905'

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER